# Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

> **NCT00608569** · NA · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 529 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Emtricitabine/Tenofovir disoproxil fumarate
- **DRUG:** Tenofovir disoproxil fumarate
- **DRUG:** Zidovudine
- **DRUG:** Emtricitabine

## Key facts

- **NCT ID:** NCT00608569
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 529 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608569, "Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00608569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*